Global reach Inomed serves hospitals in over 100 countries with a broad distributor network, indicating strong international sales potential for expanded intraoperative neuromonitoring and functional neurosurgery offerings.

Multispecialty portfolio Three core business areas (Intraoperative Neuromonitoring, Functional Neurosurgery, and Pain Treatment) create multiple cross-sell opportunities with hospitals already using neuromonitoring devices.

Clinical impact Devices support around 500,000 operations annually, suggesting high adoption and proof-of-value potential for upsell with enhanced safety features or newer monitoring technologies.

Growing partnerships Recent collaboration with Endotherapeutics adding intraoperative neuromonitoring to OHNS portfolios signals momentum for channel partnerships and co-marketing initiatives.

Mid‑market scale Revenue in the 100–250 million range with 201–500 employees positions inomed as a mid-market player; a strategic focus on mid-sized hospitals and regional centers could yield high win rates.